Effect of transfusion therapy on cerebral vasculopathy in children with sickle-cell anemia
- 1 January 2009
- journal article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 94 (1) , 123-126
Abstract
This retrospective study assessed the long-term effect of transfusional exchange therapy on MRA/MRI abnormalities in 24 homozygous sickle-cell anemia (HbSS) children presenting with abnormal brain MRA. The median time elapsed from baseline to last available MRA was 29 months. Follow-up MRAs showed improvement, stabilization or worsening of cerebrovascular lesions in 11, 6 and 7 patients respectively. Complete normalization of MRA was observed in 6 patients within a mean time of 1.4 years, but stenosis recurred at the same location in the 4 patients in whom transfusion therapy was discontinued. Baseline severe stenosis/occlusion of large cerebral arteries and occurrence of moyamoya syndrome were significantly associated with an absence of improvement of the cerebral vasculopathy. These data emphasize the heterogeneity of the course of cerebrovasculopathy in SS children receiving chronic transfusion. Further studies are needed to determine whether different therapeutic approaches have to be considered according to these different evolutive patterns in SS children.Keywords
This publication has 13 references indexed in Scilit:
- Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemiaBlood, 2007
- Pathophysiology and treatment of stroke in sickle-cell disease: present and futureThe Lancet Neurology, 2006
- Long-term follow-up of pediatric sickle cell disease patients with abnormal high velocities on transcranial DopplerPediatric Radiology, 2005
- Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP studyBlood, 2004
- Altered myocardial flow reserve and endothelial function late after Kawasaki diseaseThe Journal of Pediatrics, 2003
- Nitric oxide donor properties of hydroxyurea in patients with sickle cell diseaseBritish Journal of Haematology, 2002
- Prevention of a First Stroke by Transfusions in Children with Sickle Cell Anemia and Abnormal Results on Transcranial Doppler UltrasonographyNew England Journal of Medicine, 1998
- Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusionsThe Journal of Pediatrics, 1995
- High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell diseaseThe Journal of Pediatrics, 1991
- EFFECT OF TRANSFUSION THERAPY ON ARTERIOGRAPHIC ABNORMALITIES AND ON RECURRENCE OF STROKE IN SICKLE-CELL DISEASE1984